Application Nr Approved Date Route Status External Links
ANDA091042 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: Phendimetrazine Tartrate Is Indicated In The Management Of Exogenous Obesity As A Short Term Adjunct (A Few Weeks) In A Regimen Of Weight Reduction Based On Caloric Restriction In Patients With An Initial Body Mass Index (Bmi) Of 30 Kg/m 2 Or Higher Who Have Not Responded To Appropriate Weight Reducing Regimen (Diet And/or Exercise) Alone. Below Is A Chart Of Body Mass Index (Bmi) Based On Various Heights And Weights. Bmi Is Calculated By Taking The Patient’s Weight, In Kilograms (Kg), Divided By The Patient’s Height, In Meters (M), Squared. Metric Conversions Are As Follows: Pounds ÷ 2.2 = Kg; Inches X 0.0254 = Meters. Phendimetrazine Tartrate Is Indicated For Use As Monotherapy Only. Bmi Index

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Phendimetrazine Tartrate PHENDIMETRAZINE TARTRATE ZINC22010375

Comments